A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Public ClinicalTrials.gov record NCT06309953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Study identification
- NCT ID
- NCT06309953
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Interventions
- Miebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2024
- Primary completion
- Jun 16, 2024
- Completion
- Jun 16, 2024
- Last update posted
- Oct 20, 2025
2024
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 207 | Birmingham | Alabama | 35233 | — |
| Site 205 | Petaluma | California | 94954 | — |
| Site 203 | Pittsburg | Kansas | 66762 | — |
| Site 204 | Stillwater | Minnesota | 55082 | — |
| Site 202 | Kansas City | Missouri | 64154 | — |
| Site 201 | Brecksville | Ohio | 44141 | — |
| Site 206 | Westlake | Ohio | 44145 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06309953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2025 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06309953 live on ClinicalTrials.gov.